STAM mice had markedly elevated blood glucose levels (Figure 2C), increased serum alanine aminotransferase (ALT) levels (Figure 2D), and NASH activity scores (Figure 2E) that were evaluated microscopically (Figure 2F) from the age of 10 weeks. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.